Keybanc Flexes Confidence in Ardent Health Partners with Overweight Rating

On October 11, 2024, Keybanc started following Ardent Health Partners (NYSE: ARDT) and issued an Overweight recommendation.

Analyst Price Projection Indicates Significant Growth Potential

As of September 25, 2024, analysts set the average one-year price target for Ardent Health Partners at $23.23 per share. Predictions vary, with estimates stretching from a low of $21.21 to a high of $28.35. This average target represents a potential rise of 22.41% from the most recent closing price of $18.98 per share.

Check our leaderboard for companies with the highest price target upside.

Institutional Investor Activity

Look at some notable institutional shareholders:

• Putnam Funds Trust – Putnam Multi-cap Core Fund holds 634K shares (0.44% ownership).
• THE HARTFORD HEALTHCARE FUND (HGHAX) owns 271K shares (0.19% ownership).
• Transamerica Small Cap Value C (TSLCX) possesses 52K shares (0.04% ownership).
• John Hancock Seaport Long (JSFBX) has 32K shares (0.02% ownership).
• Science & Technology Fund Shares (USSCX) controls 4K shares (0.00% ownership).

Fintel stands out as a comprehensive investing research platform for individual investors, traders, financial advisors, and small hedge funds.

Our extensive data covers global markets, including fundamentals, analyst insights, ownership statistics, fund sentiment, insider activities, and unique options trades. Additionally, we offer exclusive stock picks based on advanced, backtested quantitative models designed for higher returns.

Click to Learn More

This article originally appeared on Fintel.

The views and opinions expressed herein are those of the author and do not necessarily represent those of Nasdaq, Inc.